<DOC>
	<DOCNO>NCT00380302</DOCNO>
	<brief_summary>Primary : This study conduct evaluate AVE1625 safe tolerate patient Alzheimer 's disease severe . There also evaluation whether patient take study medication improve compare patient take placebo ( sugar pill ) . Secondary : The study also evaluate blood level study medication , AVE1625 patient join study .</brief_summary>
	<brief_title>Activity AVE1625 Mild Moderate Alzheimer 's Patients .</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>The diagnosis Alzheimer 's disease Recent brain image ( Computerized Axial Tomographic Scan CAT scan Magnetic Resonance Imaging MRI ) Mild moderate range disease ; severe Severe unstable medical disease Neurological disorder Alzheimer 's disease Depression well control Treatment memantine Inpatient total care facility ( e.g . : Nursing home ) Lack reliable caregiver</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>symptomatic</keyword>
	<keyword>cognition</keyword>
</DOC>